{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:O14654",
      "entity_text" : "IRS4",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ07581",
      "entity_text" : "CK1gamma2",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Conclusions : IRS4, as a new substrate of CHIP, is negatively regulated by CK1gamma2 at the posttranslational level, and specific CK1gamma2 agonists may be a potentially effective strategy for treating patients with osteosarcoma.",
  "reading_complete" : "2020-08-02T17:18:49Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T17:17:08Z",
  "trigger" : "negatively regulated",
  "evidence" : [ "IRS4, as a new substrate of CHIP, is negatively regulated by CK1gamma2" ],
  "pmc_id" : "6037025",
  "score" : 0
}